Trade C4 Therapeutics, Inc. - CCCC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023651% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001429% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.85 |
| Open | 3.83 |
| 1-Year Change | -13.35% |
| Day's Range | 3.83 - 4 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 3.83 | -0.24 | -5.90% | 4.07 | 4.07 | 3.70 |
| Dec 23, 2024 | 4.02 | 0.09 | 2.29% | 3.93 | 4.18 | 3.86 |
| Dec 20, 2024 | 3.91 | 0.15 | 3.99% | 3.76 | 3.94 | 3.68 |
| Dec 19, 2024 | 3.81 | -0.13 | -3.30% | 3.94 | 4.03 | 3.66 |
| Dec 18, 2024 | 3.62 | -0.38 | -9.50% | 4.00 | 4.00 | 3.59 |
| Dec 17, 2024 | 4.01 | -0.19 | -4.52% | 4.20 | 4.40 | 3.97 |
| Dec 16, 2024 | 4.27 | 0.08 | 1.91% | 4.19 | 4.50 | 4.19 |
| Dec 13, 2024 | 4.34 | 0.02 | 0.46% | 4.32 | 4.37 | 4.01 |
| Dec 12, 2024 | 4.28 | -0.33 | -7.16% | 4.61 | 4.64 | 4.16 |
| Dec 11, 2024 | 4.68 | 0.39 | 9.09% | 4.29 | 4.86 | 4.17 |
| Dec 10, 2024 | 4.28 | 0.13 | 3.13% | 4.15 | 4.41 | 3.99 |
| Dec 9, 2024 | 4.16 | -0.69 | -14.23% | 4.85 | 5.04 | 4.06 |
| Dec 6, 2024 | 4.38 | 0.50 | 12.89% | 3.88 | 4.59 | 3.88 |
| Dec 5, 2024 | 3.87 | -0.01 | -0.26% | 3.88 | 3.92 | 3.75 |
| Dec 4, 2024 | 3.88 | -0.16 | -3.96% | 4.04 | 4.04 | 3.76 |
| Dec 3, 2024 | 4.01 | -0.19 | -4.52% | 4.20 | 4.26 | 4.01 |
| Dec 2, 2024 | 4.28 | -0.21 | -4.68% | 4.49 | 4.54 | 4.25 |
| Nov 29, 2024 | 4.51 | 0.01 | 0.22% | 4.50 | 4.59 | 4.44 |
| Nov 27, 2024 | 4.51 | 0.31 | 7.38% | 4.20 | 4.62 | 4.20 |
| Nov 26, 2024 | 4.16 | -0.13 | -3.03% | 4.29 | 4.32 | 4.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
C4 Therapeutics, Inc. Company profile
About C4 Therapeutics Inc
C4 Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on harnessing the body’s natural regulation of protein levels to develop therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. The Company provides technology platform, Target ORiented ProtEin Degrader Optimizer (TORPEDO), to synthesize a new class of small molecule protein degraders that are designed to destroy disease-causing proteins, including targets previously considered to be undruggable. The Company’s lead product candidates, CFT7455, is an orally bioavailable degrader targeting IKZF1/3 for multiple myeloma (MM), peripheral T-cell lymphoma (PTCL), and mantle cell lymphoma (MCL). The Company is also developing CFT8634, an orally bioavailable degrader of a protein target called bromodomain containing 9 (BRD9), for synovial sarcoma and SMARCB1-deleted solid tumors.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, C4 Therapeutics Inc revenues increased 38% to $45.8M. Net loss increased 26% to $83.9M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Stock-based Compensation in SGA increase from $2.5M to $14M (expense), Research and development - Balancing val increase of 12% to $87.1M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
490 Arsenal Way
Suite 120
WATERTOWN
MASSACHUSETTS 02472
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com